Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design

Author(s):  Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S

Issue:  Jan/Feb 2021 - Volume 25, Number 1
View All Articles in Issue

Page(s):  73-81

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 1
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 2
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 3
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 4
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 5
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 6
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 7
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 8
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Page 9

Download in electronic PDF format for $75

Abstract:  Trimix is a widely prescribed penile injection for patients with erectile dysfunction and is only available as a compounded medication. The instability of alprostadil, one of the major ingredients of Trimix, has been a limiting factor in its utilization. There are published stability data for Trimix formulations that have been used to establish a beyond-use-date. However, a robust bracketed study that is shown to be reproducible is highly desirable and meaningful. The purpose of this study was to test the reproducibility of a bracketed stability study when the preparations were made by two different entities to provide beyond-use date information of Trimix preparations that cover a wide range of strengths. A validated stability indicating method was used to compare the stability of a bracketed Trimix - alprostadil 5 µg/mL to 45 µg/mL, papaverine 15 mg/mL to 30 mg/mL, and phentolamine 0.4 mg/mL to 5 mg/mL, and a single-strength preparation containing alprostadil 30 µg/mL, papaverine 30 mg/mL, and phentolamine 2 mg/mL that were compounded and stored following the same methods and conditions, but at two different practice settings. Beyond-use dates of 60 days and 64 days at cold temperature were obtained for the two preparations from two different settings. The consistent results confirmed the reproducibility of the bracketing designs used to determine the beyond-use dates of Trimix. The clinical value of these results stems from the availability of accurate and widely applicable stability data that can be referenced to establish beyond use dates of a number of Trimix preparations with various strength combinations.

Related Keywords: Gopesh Patel, RPh, Courtaney Davis, CPhT, Yi Liu, PharmD, PhD, RPh, Kendice Ip, MS, Krystal E. Debideen, CPhT, Stephanie Anderson, MBA, Robert Byrne, PhD, Dylan Herr, Melissa Merrell Rhoads, PharmD, RPh, Ross Caputo, PhD, Daniel Banov, MS, RPh, August S. Bassani, PharmD, RPh, Trimix, penile injection, intracavernosal injection, corpora cavernosum, erectile dysfunction, penile erection, alprostadil, prostaglandin E1, papaverine hydrochloride, smooth muscle relaxant, cyclic adenosine monophosphate agonist, phentolamine mesylate, vasoconstriction blocker, vasodilator, drug admixture stability, physical stability, chemical stability, beyond-use date, formulations, aseptic preparations, compounded sterile preparations

Related Categories: PARENTERALS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh
, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021
Pg. 73-81

Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
Mar/Apr 2018
Pg. 129-134

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Assignment of a Beyond-Use Date for Compounded Preparations
Allen Loyd V Jr
Nov/Dec 2000
Pg. 474-475

Basics of Compounding: Clinical Studies
Allen Loyd V Jr
Nov/Dec 2002
Pg. 443-447

Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date
Thomson Cassandra Marie
, Savji Taslim
Nov/Dec 2014
Pg. 456-460

Stability Evaluation of Minoxidil in FOAMIL Form Base with Bracketing Study Design
Lupatini Rodrigo
, Sidhu Raman, Patel Harshad, Bichar Katia
May/Jun 2021
Pg. 236-240

Beyond-use Date: Establishment and Maintenance
Osteen Richard
Nov/Dec 2012
Pg. 471-474

Assignment of Beyond-Use Dates
Allen Loyd V Jr
May/Jun 2000
Pg. 222

Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
Jul/Aug 2018
Pg. 303-312

Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
Jan/Feb 2016
Pg. 81-85

Compounding for Investigational Studies: The Experience of Ken Hughes, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 436-439

Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Trissel Lawrence A
, Zhang Yanping
May/Jun 2004
Pg. 231-235

Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vail Jane
Mar/Apr 2007
Pg. 132-135

Identifying the Criteria of a Valid Stability Study
Williams LaVonn A
, Hastings Mitchell Blaine
Jan/Feb 2009
Pg. 32-36

Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
May/Jun 2014
Pg. 253-255

Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
Jul/Aug 2014
Pg. 345-347

Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita, Addo Richard T
Jul/Aug 2014
Pg. 348-350

Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory
, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017
Pg. 164-170

Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure
Ip Kendice
, Banov Daniel, Bassani Gus, Morgan Latisha
Mar/Apr 2019
Pg. 167-175

Return to Top